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Supplementary material 
Preparation and in vitro activity of gold(III) complexes with some esters of 
(S,S)-ethylenediamine-N,N’-di-2-propanoic acid 
 
Fig. S1. Calculated structures of 1c–4c. H atoms, except those bonded to chiral atoms, are omitted for clarity. 
Characterization of complex 3 as an example: 
 
Fig. S2. ESI-MS for 3. 
 
 
Fig. S3. FT-IR spectrum of 3. 
 
Fig. S4. Far FT-IR spectrum of 3. 
  
 
Fig. S5. 1H NMR spectrum of 3. 
  
Fig. S6. 13C NMR spectrum of 3. 
 
Fig. S7. 1H NMR spectrum of 3 in DMSO-d6 (#solvent; *water). 
 
Fig. S8. 13C NMR spectrum of 3 in DMSO-d6 (#solvent). 
 
 
Fig. S9. 1H NMR (500 MHz) spectrum of 3 in CDCl3 (#solvent; *water). 
 
Fig. S10. 13C NMR (500 MHz) spectrum of 3 in CDCl3 (#solvent). 
 
 
Fig. S11. Reduction of 3 with ascorbic acid followed by 13C NMR spectroscopy (#solvent).  
 
 
 
 
 
 
Fig. S12. Stability of 3 in the presence of PBS followed by 13C NMR spectroscopy (#solvent).  
 
 
 
 Fig. S13. HeLa cells were exposed to 3 and 4 (48 h) and the presence of autophagic vesicles was investigated. 
 
